| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Fairbairn Robert W is a Director at BlackRock Capital Allocation Term Trust with holdings across 5 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | BCAT Blackrock Capital Allocation Term Trust | Director | Buy | 43,141 | $22.97 | $991,121.35 | +84.4% | |
| Sep 24, 2020 | BCAT Blackrock Capital Allocation Term Trust | Director | Buy | 15,000 | $20.00 | $300,000.00 | +150.0% | |
| Jan 28, 2020 | BMEZ Blackrock Health Sciences Term Trust | Director | Buy | 15,000 | $20.00 | $300,000.00 | New |